1.
J Pharm Belg
; (2): 38-9, 2015 Jun.
Artigo
em Francês
| MEDLINE
| ID: mdl-26466508
2.
J Pharm Belg
; (3): 38-9, 2014 Sep.
Artigo
em Francês
| MEDLINE
| ID: mdl-25226762
3.
Ann Pharm Fr
; 71(6): 376-89, 2013 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24206590
RESUMO
The recommendations for the practical stability of anticancer drugs published in 2010 by the French Society of Hospital Pharmacists (SFPO) and the European Society of Oncology Pharmacists (ESOP) have been updated. Ten new molecules have been included (asparaginase, azacitidine, bevacizumab, clofarabine, eribuline mesylate, folinate sodium, levofolinate calcium, nelarabine, rituximab, temsirolimus).